)
Hyderabad-based discovery research and development organisation, GVK Bio, is set to acquire Vanta Bioscience, a contract research organisation operating out of Chennai. The company said it had signed a definitive agreement in this regard. The cost of acquisition has not been not disclosed.
GVK Bio offers toxicology evaluation services for the pharmaceutical, biotech, food supplements and feed additives industries. Vanta Bioscience also offers toxicology services using alternative methods for the cosmetics industry.
“The acquisition is in line with our business strategy of being an integrated drug discovery services provider for our customers. We are constantly investing in upgrading our capabilities to provide world-class R&D services. Vanta Bioscience further advances our position as we expand our service offering in GLP (good laboratory practice) toxicology,” GVK Bio chief executive officer, Manni Kantipudi, stated in a press release
“We are delighted to transition into an organisation that can expand our offerings and provide further opportunities to our clients and staff,” Vanta Bioscience vice president and general manager, Gerard Schwickerath, said.
